These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 19898822
1. Glutamine regulation of doxorubicin accumulation in hearts versus tumors in experimental rats. Todorova VK, Kaufmann Y, Hennings LJ, Klimberg VS. Cancer Chemother Pharmacol; 2010 Jul; 66(2):315-23. PubMed ID: 19898822 [Abstract] [Full Text] [Related]
2. Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats. Todorova VK, Kaufmann Y, Hennings L, Klimberg VS. J Nutr; 2010 Jan; 140(1):44-8. PubMed ID: 19889810 [Abstract] [Full Text] [Related]
3. Glutamine protects against doxorubicin-induced cardiotoxicity. Cao Y, Kennedy R, Klimberg VS. J Surg Res; 1999 Jul; 85(1):178-82. PubMed ID: 10383856 [Abstract] [Full Text] [Related]
4. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid. Ghibu S, Delemasure S, Richard C, Guilland JC, Martin L, Gambert S, Rochette L, Vergely C. Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425 [Abstract] [Full Text] [Related]
5. Nutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and ω-3 Polyunsaturated Fatty Acids. Xue H, Ren W, Denkinger M, Schlotzer E, Wischmeyer PE. JPEN J Parenter Enteral Nutr; 2016 Jan; 40(1):52-66. PubMed ID: 25888676 [Abstract] [Full Text] [Related]
6. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity. El-Demerdash E, Ali AA, Sayed-Ahmed MM, Osman AM. Cancer Chemother Pharmacol; 2003 Nov; 52(5):411-6. PubMed ID: 12879278 [Abstract] [Full Text] [Related]
7. Beneficial effects of carnosine and carnosine plus vitamin E treatments on doxorubicin-induced oxidative stress and cardiac, hepatic, and renal toxicity in rats. Kumral A, Giriş M, Soluk-Tekkeşin M, Olgaç V, Doğru-Abbasoğlu S, Türkoğlu Ü, Uysal M. Hum Exp Toxicol; 2016 Jun; 35(6):635-43. PubMed ID: 26224044 [Abstract] [Full Text] [Related]
8. Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation. Richard C, Ghibu S, Delemasure-Chalumeau S, Guilland JC, Des Rosiers C, Zeller M, Cottin Y, Rochette L, Vergely C. J Pharmacol Exp Ther; 2011 Dec; 339(3):807-14. PubMed ID: 21934029 [Abstract] [Full Text] [Related]
9. Exercise mitigates cardiac doxorubicin accumulation and preserves function in the rat. Jensen BT, Lien CY, Hydock DS, Schneider CM, Hayward R. J Cardiovasc Pharmacol; 2013 Sep; 62(3):263-9. PubMed ID: 23644988 [Abstract] [Full Text] [Related]
10. Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to Doxorubicin in tumor-bearing spontaneously hypertensive rats. Gonzalez Y, Pokrzywinski KL, Rosen ET, Mog S, Aryal B, Chehab LM, Vijay V, Moland CL, Desai VG, Dickey JS, Rao VA. Cancer Chemother Pharmacol; 2015 Sep; 76(3):447-59. PubMed ID: 26108538 [Abstract] [Full Text] [Related]
11. Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin. Darvari R, Boroujerdi M. Cancer Chemother Pharmacol; 2005 Nov; 56(5):497-509. PubMed ID: 15937726 [Abstract] [Full Text] [Related]
12. A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat. Hole LD, Larsen TH, Fossan KO, Limé F, Schjøtt J. Toxicol Mech Methods; 2013 Jul; 23(6):412-8. PubMed ID: 23379389 [Abstract] [Full Text] [Related]
13. Alteration of serum and cardiac tissue adropin, copeptin, irisin and TRPM2 expressions in DOX treated male rats. Aydin S, Eren MN, Kuloglu T, Aydin S, Yilmaz M, Gul E, Kalayci M, Yel Y, Cakmak T, Bico S. Biotech Histochem; 2015 Apr; 90(3):197-205. PubMed ID: 25434395 [Abstract] [Full Text] [Related]
14. Fetal rat hearts do not display acute cardiotoxicity in response to maternal Doxorubicin treatment. Gziri MM, Pokreisz P, De Vos R, Verbeken E, Debiève F, Mertens L, Janssens SP, Amant F. J Pharmacol Exp Ther; 2013 Sep; 346(3):362-9. PubMed ID: 23792410 [Abstract] [Full Text] [Related]
15. Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart. Sun XP, Wan LL, Yang QJ, Huo Y, Han YL, Guo C. Arch Pharm Res; 2017 Jul; 40(7):875-883. PubMed ID: 28315259 [Abstract] [Full Text] [Related]
16. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. Elberry AA, Abdel-Naim AB, Abdel-Sattar EA, Nagy AA, Mosli HA, Mohamadin AM, Ashour OM. Food Chem Toxicol; 2010 May; 48(5):1178-84. PubMed ID: 20146931 [Abstract] [Full Text] [Related]
17. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration. Saad SY, Najjar TA, Alashari M. J Biochem Mol Toxicol; 2004 May; 18(2):78-86. PubMed ID: 15122649 [Abstract] [Full Text] [Related]
18. Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248). Mosure KW, Henderson AJ, Klunk LJ, Knipe JO. Cancer Chemother Pharmacol; 1997 May; 40(3):251-8. PubMed ID: 9219510 [Abstract] [Full Text] [Related]
19. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats. Zordoky BN, Anwar-Mohamed A, Aboutabl ME, El-Kadi AO. Toxicol Appl Pharmacol; 2010 Jan 01; 242(1):38-46. PubMed ID: 19796650 [Abstract] [Full Text] [Related]
20. Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione. Todorova V, Vanderpool D, Blossom S, Nwokedi E, Hennings L, Mrak R, Klimberg VS. Nutrition; 2009 Jan 01; 25(7-8):812-7. PubMed ID: 19251394 [Abstract] [Full Text] [Related] Page: [Next] [New Search]